Big data-driven precision medicine: Starting the custom-made era of iatrology - 28/08/20
, Hui Luo a, ⁎ , Xiao Zhu a, ⁎ Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 12 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | Precision medicine is driven by omics and big data. |
• | Precision medicine is widely used in various kinds of diseases. |
• | Precision medicine still has some limitations, but it has a bright future. |
Abstract |
Precision medicine is a new therapeutic concept and method emerging in recent years. The rapid development of precision medicine is driven by the development of omics related technology, biological information and big data science. Precision medicine is provided to implement precise and personalized treatment for diseases and specific patients. Precision medicine is commonly used in the diagnosis, treatment and prevention of various diseases. This review introduces the application of precision medicine in eight systematic diseases of the human body, and systematically presenting the current situation of precision medicine. At the same time, the shortcomings and limitations of precision medicine are pointed out. Finally, we prospect the development of precision medicine.
Le texte complet de cet article est disponible en PDF.Abbreviations : ATB, AIN, AKI, ACAT2, ARPC5, AD, AKT, BMP-2, BMP-2n, BMI, BRCA2, BET, BRD2, BRD3, BRD4, CRISPR, CRP, Copd, CKD, Cys, CLUS, CEMIP, cHCC-CC, ctDNA, CD24, CLU, CTNNB1, DKK3, DPP-4, DNA, DJ-1, DHCR24, eRNA, EGFR, ER, ESR1, ERBB2, FDA, FOXO3, FCN2, FDFT1, GAD, Hcy, HA, HbA1C, HOMA-β, HOMA-IR, HCV, HIV, HAUSP, HER-2, IPF, IgA, IL-9, IBD, IBD1, IBD2, IPO11, KL-6, KDR, LP-PLA2, LTB, LRRK2, MMP-2, MAIT, miRNA, mTOR, MALAT-1, MIF, MMP1, mNGS, MUC1, MAPT, Nanopro 1000, NAFLD, NGS, NSCLC, OS, PIGR, POF, PARP, PARP1, PD-1, PCGEM1, PLA2G7, PARK7, PGR, PDCD1, RNA-seq, ROS, ROS1, RAGE-Seq, RAC1, Smurf1, Smurf1e, SP-D, SERD, SFTPD, SNCA, SPOP, TB, T1D, T2DM, TNA, ThyroSeq, Usp7, VEGFR2, YAP, YAP1, YKi
Keywords : Precision medicine, Omics, Sequencing, Medical big data, Biomarker
Plan
Vol 129
Article 110445- septembre 2020 Retour au numéro
Article précédent
- Exosomes: Multiple-targeted multifunctional biological nanoparticles in the diagnosis, drug delivery, and imaging of cancer cells
- Yuzhong Zheng, Anwarul Hasan, Mohammad Mahdi Nejadi Babadaei, Elham Behzadi, Mina Nouri, Majid Sharifi, Mojtaba Falahati
- Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease
- Veerta Sharma, Amarjot Kaur, Thakur Gurjeet Singh
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?